Related Experiment Videos
Beyond the limits of typical antidepressants
1Istituto di Farmacologia e Farmacognosia, Universita' La Sapienza, Roma, Italia.
Psychopharmacology
|January 1, 1988
Summary
Trazodone and tricyclic antidepressants impact depression core symptoms similarly but differ in neurohumoral effects. Trazodone
Area of Science:
- Neuroscience
- Pharmacology
- Psychiatry
Background:
- Tricyclic antidepressants (TCAs) and trazodone are used for depression.
- Existing depression theories are based on monoamine oxidase inhibitors (MAOIs) and TCAs.
- Autonomic nervous system (ANS) changes are observed in depression.
Purpose of the Study:
- To compare the effects of trazodone and TCAs on depression symptoms.
- To investigate the contrasting effects on neurohumoral transmission.
- To examine the differential impact on the autonomic nervous system.
Main Methods:
- Comparative analysis of trazodone and TCAs.
- Evaluation of neurohumoral transmission.
- Assessment of autonomic nervous system activity.
Main Results:
- Trazodone and TCAs show similar efficacy for core depressive symptoms.
- Neurohumoral effects of trazodone and TCAs are opposite.
- Trazodone exhibits alpha-adrenergic blocking activity, unlike TCAs' muscarinic-anticholinergic and alpha-adrenergic stimulating properties.
- Autonomic changes associated with depression, partly mimicked by TCAs, are relieved by trazodone.
Conclusions:
- Findings challenge current depression theories derived from MAOIs and TCAs.
- Trazodone's distinct autonomic effects offer an advantage over TCAs.
- Trazodone expands therapeutic options beyond the limitations of traditional antidepressants.